| Abstract | It is advised to understand present status of vaccines to start of review history of vaccine development. Any vaccine currently used has some problems to be improved. In addition to the efficacy or safety, cost of vaccine provide a problem. Drugs and Cosmetics Act describes regulations to ensure quality of vaccines. The Minimum Requirement of Biological Products concerns a soft ware of vaccines and GMP regulates hard ware of vaccine production. Some vaccines such as malaria, AIDS, hepatitis C vaccines are on the way of development in the world. New technology such as DNA vaccines or vaccine for application to mucous membranes are being applied. A new concept of vaccine is presented as a prophylactic tools for cancer, auto-immune diseases or allergic diseases which some key proteins are known as triggers. |
| Authors | A Oya
(Affiliation: R & D Center BML Inc., Kawagoe 350-1101.)
|
| Journal | Rinsho byori. The Japanese journal of clinical pathology
(Rinsho Byori)
Vol. 49
Issue 7
Pg. 667-8
(Jul 2001)
ISSN: 0047-1860 Japan |
| PMID | 11519127
(Publication Type: English Abstract, Journal Article, Review)
|
| Chemical References |
- Vaccines
- Vaccines, DNA
- Vaccines, Inactivated
|
| Topics |
- Animals
- Forecasting
- Humans
- Quality Control
- Vaccines
- Vaccines, DNA
- Vaccines, Inactivated
|
